Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium

Fig. 2

Kaplan–Meier curves of the cumulative incidence of the ASCVD events between the ICI and the non-ICI group after PSM. (A) Cumulative incidence for the total ASCVD event. (B-D) Cumulative incidence for the individual components of the ASCVD events. Abbreviations: HR, hazard ratio; ASCVD, atherosclerotic cardiovascular disease; ICI, immune checkpoint inhibitor; PSM, propensity score matching

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us